Early-stage biotechnology company developing RNA-based therapeutics
miRecule develops next-generation RNA therapeutics to treat a variety of diseases including cancer and muscular dystrophy.
Developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue
Neuroimaging AI software solutions that transform outcomes for research, clinical trials, and care delivery
Working at the frontier of vascular and musculoskeletal tissue regeneration